J P Ioannidis

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    JAMA 279:281-6. 1998
  2. ncbi request reprint Issues in comparisons between meta-analyses and large trials
    J P Ioannidis
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852, USA
    JAMA 279:1089-93. 1998
  3. ncbi request reprint Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
    J P Ioannidis
    HIV Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Infect Dis 178:349-59. 1998
  4. ncbi request reprint Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient
    J P Ioannidis
    Therapeutics Research Program, DAIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Epidemiol 51:709-11. 1998
  5. ncbi request reprint Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop
    J M Albert
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 7620, USA
    Stat Med 17:2435-62. 1998
  6. ncbi request reprint Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 20:129-36. 1999
  7. ncbi request reprint Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
    Int J Epidemiol 28:769-75. 1999
  8. ncbi request reprint Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy
    T R O'Brien
    Viral Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA
    AIDS 14:821-6. 2000

Detail Information

Publications8

  1. ncbi request reprint Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    JAMA 279:281-6. 1998
    ..Medical evidence may be biased over time if completion and publication of randomized efficacy trials are delayed when results are not statistically significant...
  2. ncbi request reprint Issues in comparisons between meta-analyses and large trials
    J P Ioannidis
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852, USA
    JAMA 279:1089-93. 1998
    ..The extent of concordance between meta-analyses and large trials on the same topic has been investigated with different protocols. Inconsistent conclusions created confusion regarding the validity of these major tools of clinical evidence...
  3. ncbi request reprint Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
    J P Ioannidis
    HIV Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Infect Dis 178:349-59. 1998
    ....
  4. ncbi request reprint Uncontrolled pearls, controlled evidence, meta-analysis and the individual patient
    J P Ioannidis
    Therapeutics Research Program, DAIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Clin Epidemiol 51:709-11. 1998
    ..Concurrent progress in basic sciences revolutionizing our predictive power for disease outcomes will heighten the importance of considering individual heterogeneity...
  5. ncbi request reprint Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop
    J M Albert
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 7620, USA
    Stat Med 17:2435-62. 1998
    ..These issues will be critical in the proper assessment and use of future therapies for HIV disease...
  6. ncbi request reprint Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Acquir Immune Defic Syndr Hum Retrovirol 20:129-36. 1999
    ..The correlation between viral load and HLA markers suggests a possible HLA effect on setting viral load levels...
  7. ncbi request reprint Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi
    J P Ioannidis
    HIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA
    Int J Epidemiol 28:769-75. 1999
    ..A better understanding of the characteristics and the impact of women and children lost to follow-up is needed...
  8. ncbi request reprint Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy
    T R O'Brien
    Viral Epidemiology Branch, National Cancer Institute, Bethesda, Maryland, USA
    AIDS 14:821-6. 2000
    ..In comparison with subjects with other genotypes, the prognosis for HIV-1-infected CCR5-delta32 heterozygotes is more favorable and that for CCR5 promoter allele 59029A homozygotes is less favorable...